Vital Living Signs Distribution Agreement for China With AHI Management; Vital Living's Nutraceuticals to Be Supplied to Chinese Hospitals.Business Editors & Health/Medical Writers TEMPE, Ariz.--(BW HealthWire)--May 17, 2002 Vital Living, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :VTLV), The Physician Nutraceutical nu·tra·ceu·ti·cal n. A food or naturally occurring food supplement thought to have a beneficial effect on human health. nutraceutical Company(SM), today announced it has signed an exclusive agreement with AHI AHI, n.pr See Aviation Health Institute. Management (AHIM) to distribute Vital Living's cardiovascular nutraceuticals throughout China. AHIM will operate in conjunction with its affiliate, Advanced Medical China Hong Kong Hong Kong (hŏng kŏng), Mandarin Xianggang, special administrative region of China, formerly a British crown colony (2005 est. pop. 6,899,000), land area 422 sq mi (1,092 sq km), adjacent to Guangdong prov. Ltd. (AMC (Advanced Mezzanine Card) See AdvancedTCA. ), to distribute Vital Living's nutraceuticals. AMC maintains a database of over 400 Chinese cardiovascular specialists and sells medical devices to many Chinese hospitals for the treatment of cardiovascular patients. Each year, AMC hosts major cardiovascular conferences in China and trains Chinese physicians B
AHIM has received approval from China's Ministry of Health to develop the first private joint-venture specialty hospital in Beijing, the Beijing International Heart Hospital (BIHH). BIHH will become China's first foreign-owned and managed cardiovascular hospital in China's capital city. China's Ministry of Health issued BIHH its business license in December 2001, and BIHH is planned to be operational by the third quarter of 2003. AHIM founder Kevin MacDonald said, "The introduction of clinically proven nutraceuticals and lifestyle management programs are indicative of our commitment to provide the latest technologies for diagnosis, treatment and intervention of cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease . Chinese pre-disposition to herbal medicine herbal medicine, use of natural plant substances (botanicals) to treat and prevent illness. The practice has existed since prehistoric times and flourishes today as the primary form of medicine for perhaps as much as 80% of the world's population. makes Vital Living a natural extension to our product offering to Chinese physicians. In addition to our distribution business, we anticipate seeing over 25,000 patients annually at BIHH, and we look forward to incorporating Vital Living's nutraceuticals for our patients. The Beijing International Heart Hospital will act as a model for cardiovascular healthcare and education in China serving the newly emerged middle-class." Cardiovascular disease (CVD CVD Cardiovascular disease, see there ) is the leading cause of death in China and affects forty percent of its 1.3 billion population, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the China 2001 Medical Report. The rapid increase in CVD patients is attributed to changes in diet and a high smoking rate. Please refer to the following Wall Street Journal Online article for more details on the impending im·pend intr.v. im·pend·ed, im·pend·ing, im·pends 1. To be about to occur: Her retirement is impending. 2. CVD health crisis in China: "Study Shows Risk of Heart Disease, Strokes Soaring Throughout China." (http://online.wsj.com/article_email/0,,SB1019673488650003880,00.html) About Vital Living Vital Living develops and markets evidence-based nutraceuticals formulated by physicians for distribution through physicians. The company is developing and testing nutraceuticals in collaboration with leading medical experts based on the best available scientific evidence. Vital Living's nutraceuticals are designed to be incorporated by physicians into a standard physician/patient program, supported by a specially designed compliance regimen. The Company's initial area of focus is cardiovascular health, the leading health concern in America affecting 60 million consumers. Except for any historical information, the matters discussed in this press release contain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the Company's ability to continue to successfully market and provide its products and services and maintain their effectiveness, the continuation of the arrangements with the Company's product development partners, the ability of the Company to meet its financial projections, and general economic conditions. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update or revise forward-looking statements whether as a result of new information or otherwise. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion